PD-1/PD-L1 inhibitors

Abstract Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.

Saved in:
Bibliographic Details
Main Authors GRAUPE, Michael, PARKHILL, Eric Q, WANG, Peiyuan, WATKINS, William J, NADUTHAMBI, Devan, METOBO, Samuel E, CHO, Aesop, MUKHERJEE, Prasenjit Kumar, DU, Zhimin, ZIEBENHAUS, Christopher Allen, MEDLEY, Jonathan William, AKTOUDIANAKIS, Evangelos, LAD, Lateshkumar Thakorlal, XU, Jie, MACHICAO TELLO, Paulo A, PHILLIPS, Barton W, SQUIRES, Neil H, YANG, Kin Shing, SIMONOVICH, Scott Preston
Format Patent
LanguageEnglish
Published 16.02.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Abstract Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
Bibliography:Application Number: AU20210204222